1.
J Microbiol Immunol Infect
; 56(6): 1288-1292, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37517964
RESUMO
Ten years after the introduction of the pneumococcal conjugate vaccine (PCV) in Japan, the prevalence rates of non-PCV13 and non-PCV20 serotypes among pediatric pneumococcal isolates were 94.0% and 73.7%, respectively. The predominant non-PCV13/PCV20 serotypes (15A, 35B, and 23A) were mostly multidrug-resistant (≥80.5%), exhibiting non-susceptibility to penicillin.